Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
Xeris Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 71.54M | 60.12M | 60.1M | 54.27M | 48.06M | 40.64M | 44.39M | 48.32M | 38.01M | 33.2M | 33.14M | 29.73M | 25.31M | 22.07M | 21.43M | 11.04M | 8.91M | 8.05M |
Cost of Revenue | 8.73M | 8.73M | 9.48M | 13.59M | 10.5M | 5.97M | 10.28M | 8.2M | 7.55M | 5.32M | 6.29M | 5.26M | 4.81M | 6.27M | 4.89M | 3.22M | 3.38M | 1.83M |
Gross Profit | -51.39M | 51.39M | 50.62M | 40.67M | 37.56M | 34.67M | 34.11M | 40.12M | 30.45M | 27.88M | 26.85M | 24.46M | 20.5M | 15.8M | 16.54M | 7.82M | 5.52M | 6.22M |
Operating Income | 4.48M | -3.09M | 1.68M | -12.89M | -8.19M | -14.24M | -9.84M | -4.91M | -15.98M | -13.28M | -15.17M | -18.78M | -18.92M | -29.07M | -48.27M | -24.36M | -25.79M | -16.74M |
Interest Income | -1.18M | 1.18M | 910K | 1.2M | 1.29M | 1.92M | 1.11M | 1.12M | 1.22M | 1.3M | 1.84M | 472K | 195K | 68K | 70K | 66K | 77K | 100K |
Pretax Income | -1.93M | -9.22M | -5.11M | -19.06M | -14.26M | -18.67M | -13.63M | -12.53M | -20.52M | -16.83M | -13.27M | -22.17M | -26.52M | -34.12M | -50.79M | -26.01M | -27.52M | -18.41M |
Net Income | -1.93M | -9.22M | -5.11M | -15.74M | -15.01M | -18.98M | -13.39M | -12.19M | -19.84M | -16.83M | -12.93M | -21.83M | -26.18M | -33.71M | -50.79M | -26.01M | -27.52M | -18.41M |
Selling & General & Admin | 44.39M | 44.02M | 40.14M | 44.97M | 39.99M | 38.38M | 37.57M | 37.29M | 37.63M | 33.6M | 34.36M | 34.49M | 32.98M | 35.91M | 54.18M | 26.54M | 25.93M | 19.08M |
Research & Development | 8.05M | 7.75M | 6.09M | 5.89M | 5.76M | 7.82M | 6.38M | 5.03M | 6.09M | 4.84M | 4.96M | 6.04M | 3.72M | 6.25M | 10.08M | 5.66M | 5.38M | 4.03M |
Other Expenses | 5.88M | 2.71M | 2.71M | 2.71M | n/a | 2.71M | n/a | -7.61M | -4.54M | -3.56M | 2.71M | -3.39M | 2.71M | 2.71M | n/a | -25K | n/a | n/a |
Operating Expenses | 58.33M | 54.48M | 48.94M | 53.57M | 45.75M | 48.91M | 43.95M | 42.32M | 46.43M | 41.15M | 42.02M | 43.24M | 39.41M | 44.87M | 64.81M | 32.17M | 31.31M | 22.96M |
Interest Expense | -7.3M | 7.3M | 7.7M | 7.79M | 7.96M | 7.03M | 7.02M | 6.85M | 6.53M | 6.22M | 4.37M | 3.99M | 3.45M | 3.52M | 1.8M | 1.8M | 1.79M | 1.79M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 67.06M | 63.21M | 58.42M | 67.16M | 56.25M | 54.88M | 54.23M | 53.23M | 53.99M | 46.47M | 48.31M | 48.51M | 44.22M | 51.15M | 69.7M | 35.39M | 34.69M | 24.79M |
Income Tax Expense | n/a | n/a | n/a | -3.32M | 749K | 307K | -236K | 338K | -675K | n/a | -338K | -339K | -339K | -408K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 155.97M | 152.45M | 149.09M | 148.99M | 148.35M | 140.51M | 138.12M | 138.06M | 137.34M | 137.14M | 135.99M | 135.95M | 135.53M | 135.03M | 121.72M | 66.5M | 66.37M | 61.25M |
Shares Outstanding (Diluted) | 155.97M | 152.45M | 149.09M | 148.99M | 148.35M | 140.51M | 138.12M | 138.06M | 137.34M | 137.14M | 135.99M | 135.95M | 135.53M | 135.03M | 121.94M | 66.5M | 66.37M | 61.25M |
EPS (Basic) | -0.01 | -0.06 | -0.03 | -0.11 | -0.1 | -0.14 | -0.1 | -0.09 | -0.14 | -0.12 | -0.1 | -0.16 | -0.19 | -0.25 | -0.42 | -0.39 | -0.41 | -0.3 |
EPS (Diluted) | -0.01 | -0.06 | -0.03 | -0.11 | -0.1 | -0.14 | -0.1 | -0.09 | -0.14 | -0.12 | -0.1 | -0.16 | -0.19 | -0.25 | -0.42 | -0.39 | -0.41 | -0.3 |
EBITDA | 1.34M | 1.23M | 5.72M | -8.15M | -3.14M | -8.43M | -3.35M | -2.32M | -10.63M | -7.44M | -5.4M | -15.11M | -20.01M | -27.57M | -48.09M | -23.89M | -25.4M | -16.28M |
EBIT | n/a | -1.92M | 2.59M | -11.28M | -6.29M | -11.64M | -6.61M | -5.68M | -13.99M | -10.62M | -8.9M | -18.18M | -23.08M | -30.6M | -48.99M | -24.21M | -25.72M | -16.62M |
Depreciation & Amortization | -3.14M | 3.14M | 3.13M | 3.12M | 3.15M | 3.21M | 3.26M | 3.36M | 3.36M | 3.18M | 3.5M | 3.07M | 3.06M | 3.03M | 899K | 323K | 320K | 337K |